Allergy Therapeutics (AGY.LSE) Q1 2026 Earnings

31MarConfirmed
Q1 2025
Q3 2025
Q4 2025
Q1 2026
-0.53
-0.43
-0.33
-0.22

Details

Expected EPS
-0.38664478336
Actual EPS
-0.38664478336
Surprise EPS
0
Surprise Percent
+0%

Description

Allergy Therapeutics (AGY.LSE) has reported earnings of -0.38664478336 per share for Q1 2026.

0 Comments

Share your thoughts